Assyro AI

Orange Book product · Brand (NDA)

POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Brand (NDA)NDA 018365TE APRX OTSUKA ICU MEDCL

At a glance

Approved Prior to Jan 1, 1982

Approved

Brand (NDA)

Application

AP

TE code

None

Listed patents

Key dates

No patent or exclusivity dates are listed for this product.

Pharmaceutical detail

Active ingredient

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Strength

5GM/100ML;149MG/100ML;225MG/100ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

NDA 018365

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.